Barry I. Hudson
- Clinical Biochemistry top 0.05%
- Molecular Biology top 10%
- Endocrinology, Diabetes and Metabolism top 1%
- Immunology top 5%
- Physiology top 5%
- Co-authors
- Ann Marie SchmidtMarc E. LippmanAnastasia Z. KaleaPeter J. GrantMax H. SticklandEvis HarjaVivette D. D’AgatiShi Fang Yan
- Topics
- Advanced Glycation End Products research (43 papers)Diabetes, Cardiovascular Risks, and Lipoproteins (15 papers)S100 Proteins and Annexins (14 papers)
- Journals
- Proceedings of the National Academy of SciencesJournal of Biological ChemistryJournal of Clinical Investigation
- Partner nations
- United StatesUnited KingdomSweden
In The Last Decade
Barry I. Hudson
61 papers receiving 4.4k citations
Hit Papers
Peers
Comparison fields: 5 of 124
- Clinical Biochemistry 2.8k
- Molecular Biology 1.2k
- Endocrinology, Diabetes and Metabolism 1.1k
- Immunology 695
- Physiology 458
Countries citing papers authored by Barry I. Hudson
This map shows the geographic impact of Barry I. Hudson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barry I. Hudson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barry I. Hudson more than expected).
Fields of papers citing papers by Barry I. Hudson
This network shows the impact of papers produced by Barry I. Hudson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barry I. Hudson. The network helps show where Barry I. Hudson may publish in the future.
Co-authorship network of co-authors of Barry I. Hudson
This figure shows the co-authorship network connecting the top 25 collaborators of Barry I. Hudson. A scholar is included among the top collaborators of Barry I. Hudson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Barry I. Hudson. Barry I. Hudson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 24 | |
| 3 | 5 | |
| 4 | 7 | |
| 5 | 14 | |
| 6 | 46 | |
| 7 | 56 | |
| 8 | 28 | |
| 9 | 36 | |
| 10 | 37 | |
| 11 | 14 | |
| 12 | 154 | |
| 13 | 35 | |
| 14 | 80 | |
| 15 | 64 | |
| 16 | 141 | |
| 17 | 203 | |
| 18 | Glycation and diabetes: The RAGE connection | 41 |
| 19 | 321 | |
| 20 | 12 |
About Barry I. Hudson
Barry I. Hudson is a scholar working on Clinical Biochemistry, Endocrinology, Diabetes and Metabolism and Biological Psychiatry, having authored 65 papers that have together received 4.5k indexed citations. Recurring topics across this work include Advanced Glycation End Products research (43 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (15 papers) and S100 Proteins and Annexins (14 papers). The work is most often cited by research in Clinical Biochemistry (2.8k citations), Endocrinology, Diabetes and Metabolism (1.1k citations) and Nephrology (308 citations). Barry I. Hudson has collaborated with scholars based in United States, United Kingdom and Sweden. Frequent co-authors include Ann Marie Schmidt, Marc E. Lippman, Anastasia Z. Kalea, Peter J. Grant, Max H. Stickland, Evis Harja, Vivette D. D’Agati, Shi Fang Yan, Éric Boulanger and T. Simon Futers. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.